Norris Perne & French’s Opko Health OPK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $42.2K | Hold |
32,000
| – | – | ﹤0.01% | 153 |
|
|
2025
Q1 | $53.1K | Buy |
32,000
+2,000
| +7% | +$3.32K | ﹤0.01% | 143 |
|
|
2024
Q4 | $44.1K | Buy |
30,000
+3,000
| +11% | +$4.41K | ﹤0.01% | 142 |
|
|
2024
Q3 | $40.2K | Buy |
27,000
+2,000
| +8% | +$2.98K | ﹤0.01% | 145 |
|
|
2024
Q2 | $31.3K | Hold |
25,000
| – | – | ﹤0.01% | 143 |
|
|
2024
Q1 | $30K | Hold |
25,000
| – | – | ﹤0.01% | 145 |
|
|
2023
Q4 | $37.8K | Hold |
25,000
| – | – | ﹤0.01% | 135 |
|
|
2023
Q3 | $40K | Hold |
25,000
| – | – | ﹤0.01% | 128 |
|
|
2023
Q2 | $54.3K | Buy |
25,000
+5,000
| +25% | +$10.9K | ﹤0.01% | 130 |
|
|
2023
Q1 | $29.2K | Sell |
20,000
-37,000
| -65% | -$54K | ﹤0.01% | 133 |
|
|
2022
Q4 | $71.3K | Sell |
57,000
-9,000
| -14% | -$11.3K | 0.01% | 136 |
|
|
2022
Q3 | $125K | Hold |
66,000
| – | – | 0.01% | 129 |
|
|
2022
Q2 | $167K | Sell |
66,000
-1,000
| -1% | -$2.53K | 0.02% | 132 |
|
|
2022
Q1 | $230K | Hold |
67,000
| – | – | 0.02% | 141 |
|
|
2021
Q4 | $322K | Hold |
67,000
| – | – | 0.03% | 114 |
|
|
2021
Q3 | $245K | Buy |
67,000
+7,000
| +12% | +$25.6K | 0.02% | 125 |
|
|
2021
Q2 | $243K | Hold |
60,000
| – | – | 0.02% | 125 |
|
|
2021
Q1 | $257K | Buy |
60,000
+500
| +0.8% | +$2.14K | 0.02% | 114 |
|
|
2020
Q4 | $235K | Buy |
59,500
+7,000
| +13% | +$27.6K | 0.02% | 146 |
|
|
2020
Q3 | $194K | Buy |
52,500
+500
| +1% | +$1.85K | 0.02% | 146 |
|
|
2020
Q2 | $177K | Buy |
52,000
+18,500
| +55% | +$63K | 0.02% | 133 |
|
|
2020
Q1 | $45K | Buy |
33,500
+20,000
| +148% | +$26.9K | 0.01% | 113 |
|
|
2019
Q4 | $20K | Buy |
+13,500
| New | +$20K | ﹤0.01% | 142 |
|
|
2017
Q4 | – | Sell |
-10,100
| Closed | -$69K | – | 154 |
|
|
2017
Q3 | $69K | Buy |
+10,100
| New | +$69K | 0.01% | 152 |
|